Skip to main content
Shop Plans Learn more about our coverage options including health, Medicare, dental and vision options for you, your family or your employees. Get Started Individual & Family Medicare Employer Vision Dental International Travel Find Care FAQ Blog Members Stay on top of your health care with helpful member resources. Members Home Medicare Health Dental Vision Find Care Member Knowledge Center Member Forms Medicare Forms Library Make a Payment Federal Employees Student Blue Healthy Blue Providers Access tools, policies and the latest information to help you care for our members. Providers Home Network Participation Networks & Programs Claims, Appeals & Inquiries Prior Authorization Services & CPT codes Prescription Drug Search Policies, Guidelines & Codes Provider News Provider FAQ Contact Us Employers Learn about our coverage options for small and large employers, and access tools and resources for your group. Employers Home Shop Employer Plans Employer Portal Support Member Forms & Resources Find Care Blog Agents Access the tools you need: rate quotes, applications, forms, the latest industry news, marketing materials and more. Agents Home Agent Services Check Eligibility Support Find Care Member Forms & Resources Medicare Forms Library
Contact Us
Log In
I am ... Please select A member A provider An employer An agent
Log in to Agent Services Register for Agent Services
Log in to Employer Services Register for Employer Services I'm registered but need portal access
Username Forgot username? Continue to Log In Register for Blue Connect Need help? Learn how to log in.
Log in to Blue e Register for Blue e Log in to Dental Blue
Back
Injectable Oncology Medical Program Update September 21, 2022 Products & Programs Claims & Coding

Effective October 1, 2022, Herceptin Hylecta and Rituxan Hycela products will now be added to Blue Cross and Blue Shield of North Carolina’s (Blue Cross NC) ’s Preferred Injectable Oncology Program policy as non-preferred products. 

These products will no longer require submission through the AIM Provider Portal in Blue e. Requests for these products for an applicable commercial member will need to be submitted through CoverMyMeds instead of through the AIM portal starting 10/1/2022. 

AIM will continue to conduct clinical reviews for all other drugs in the AIM medical oncology program. 

For more information, please refer to the medical policy (PDF) or refer to Getting Your Patient's Prescriptions Covered.  

What you should know 

  • This change applies to all commercial members with the AIM oncology program through Blue Cross NC
  • This follows a similar process to how our other medical drugs are reviewed at Blue Cross NC
  • We do not anticipate any member disruption.